Inogen to Report First Quarter 2025 Financial Results on May 7, 2025

Rhea-AI Summary

Inogen (NASDAQ: INGN), a medical technology company specializing in innovative respiratory products for homecare, has scheduled its first quarter 2025 financial results announcement for May 7, 2025, after market close.

The company will host a conference call the same day at 2:00 p.m. PT / 5:00 p.m. ET. Investors can join via phone using the following numbers: US domestic (877) 841-3961 and Non-US (201) 689-8589. A live audio webcast will be available through the News / Events page on Inogen's Investor Relations website, with a 6-month archive period. Call replay access will be available until May 14, 2025, via (877) 660-6853 or (201) 612-7415 with Conference ID: 13752582.

GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2025 financial results after the market closes on Wednesday, May 7, 2025. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET.

Individuals interested in listening to the conference call may do so by dialing:

US domestic callers (877) 841-3961
Non-US callers (201) 689-8589

Please reference Inogen to join the call. A live audio webcast and archived recording of the conference call will be available to all interested parties through the News / Events page on the Inogen Investor Relations website. This webcast will also be archived on the website for 6 months.

A replay of the call will be available approximately three hours after the live webcast ends and will be accessible through May 14, 2025. To access the replay, dial (877) 660-6853 or (201) 612-7415 and reference Conference ID: 13752582.

Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

About Inogen

Inogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class respiratory therapy devices used to deliver care to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products widely available, allowing patients the chance to manage the impact of their disease.

For more information, please visit www.inogen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250416404994/en/

ir@inogen.net

Source: Inogen, Inc.

FAQ

When will Inogen (INGN) release Q1 2025 earnings?

Inogen will release Q1 2025 earnings after market close on Wednesday, May 7, 2025.

How can investors access Inogen's Q1 2025 earnings call?

Investors can join via phone (US: 877-841-3961, Non-US: 201-689-8589) or through the live webcast on Inogen's Investor Relations website.

How long will Inogen's Q1 2025 earnings webcast be available?

The earnings webcast will be archived on Inogen's website for 6 months.

What is the replay information for Inogen's Q1 2025 earnings call?

Call replay will be available until May 14, 2025, at 877-660-6853 or 201-612-7415 with Conference ID: 13752582.